脓毒症患者淋巴细胞亚群分析及其对预后的影响
该回顾性研究纳入郑州大学第一附属医院外科ICU 2020年1月至2021年12月收治的279例符合Sepsis-3诊断且≥18岁的脓毒症患者,入院次日晨采集外周静脉血检测淋巴细胞亚群。按28天生存分为死亡组81例与存活组198例,28天死亡率29.0%。死亡组APACHE II、中性粒细胞百分比、降钙素原、血小板分布宽度高于存活组,淋巴细胞百分比、淋巴细胞计数、血小板计数、血小板压积低于存活组;死亡组淋巴细胞、CD3+、CD3+CD4+、CD19+绝对值低于存活组。Logistic回归未筛选出有统计学意义的免疫预后标志物。作者认为早期监测上述指标可评估病情和预后。
要点
- 279例脓毒症患者28天死亡81例(29.0%),存活198例(71.0%),死亡组与存活组年龄、性别无显著差异(均P>0.05)。
- 死亡组APACHE II 22.06±0.08 vs 存活组14.08±0.52(P<0.001),降钙素原11.97±2.73 μg/L vs 5.76±1.08 μg/L(P=0.011)。
- 死亡组淋巴细胞绝对值650.24±84.67个/μL vs 存活组876.64±38.02个/μL(P=0.005),CD3+绝对值445.30±57.33个/μL vs 606.84±29.25个/μL(P=0.006)。
- 死亡组CD3+CD4+绝对值239.97±26.96个/μL vs 存活组353.49±18.59个/μL(P=0.001),CD19+绝对值111.10±18.66个/μL vs 150.30±10.15个/μL(P=0.049)。
- Logistic回归分析显示淋巴细胞亚群未被筛选为对脓毒症预后有统计学意义的免疫标志物。
适用人群与场景
- 郑州大学第一附属医院外科ICU(SICU)2020年1月至2021年12月收治的脓毒症患者,符合Sepsis-3诊断标准且年龄≥18岁。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3标准。
- 按28天生存状态分为死亡组与存活组。
处置流程与药物剂量
- 所有患者于入住SICU后次日晨采集外周静脉血,行血常规及外周血淋巴细胞亚群检测。
研究设计与关键结果
- 回顾性分析279例脓毒症患者,28天存活198例(71.0%),死亡81例(29.0%);死亡组与存活组年龄(57.81±1.71岁 vs 54.99±1.05岁)、性别(男性60.5% vs 63.6%)差异均无统计学意义(均P>0.05)。
- 死亡组APACHE II评分(22.06±0.08 vs 14.08±0.52,P<0.001)、中性粒细胞百分比[(88.90±1.09)% vs (84.12±0.77)%,P=0.001]、降钙素原(11.97±2.73 μg/L vs 5.76±1.08 μg/L,P=0.011)、血小板分布宽度(16.81±0.10 fL vs 16.57±0.06 fL,P=0.029)高于存活组;淋巴细胞百分比[(6.98±0.78)% vs (10.59±0.86)%,P=0.012]、淋巴细胞计数(0.70±0.06×10⁹/L vs 0.98±0.49×10⁹/L,P=0.002)、血小板计数(151.38±13.96×10⁹/L vs 205.80±9.38×10⁹/L,P=0.002)、血小板压积[(0.15±0.01)% vs (0.19±0.07)%,P=0.012]低于存活组
- 死亡组与存活组淋巴细胞亚群百分比差异均无统计学意义;死亡组淋巴细胞绝对值(650.24±84.67个/μL vs 876.64±38.02个/μL,P=0.005)、CD3+绝对值(445.30±57.33个/μL vs 606.84±29.25个/μL,P=0.006)、CD3+CD4+绝对值(239.97±26.96个/μL vs 353.49±18.59个/μL,P=0.001)、CD19+绝对值(111.10±18.66个/μL vs 150.30±10.15个/μL,P=0.049)低于存活组。
- 死亡组CD3+CD8+绝对值(172.40±24.34个/μL vs 211.22±11.95个/μL,P=0.112)、NK绝对值(101.26±18.15个/μL vs 114.72±7.64个/μL,P=0.420)、NKT绝对值(33.22±5.13个/μL vs 39.43±2.85个/μL,P=0.262)、CD4-CD8-绝对值(41.07±11.07个/μL vs 48.84±3.31个/μL,P=0.510)、CD4+CD8+绝对值(3.39±1.45个/μL vs 3.47±0.36个/μL,P=0.943)与存活组差异均无统计学意义。
- Logistic回归分析显示,淋巴细胞亚群未被筛选为对脓毒症预后有统计学意义的免疫标志物。
证据类型、等级与局限
- 研究类型:回顾性分析;样本量279例;单中心(郑州大学第一附属医院外科ICU);证据等级:原文未给出。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症患者免疫指标变化与预后密切相关,早期监测上述指标可准确评估脓毒症患者的病情和预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the characteristics of changes in peripheral blood lymphocyte subsets in patients with sepsis in intensive care unit (ICU) and analyze their predictive value for prognosis.
METHODS: The clinical data of sepsis patients admitted to the surgical intensive care unit (SICU) of the First Affiliated Hospital of Zhengzhou University from January 2020 to December 2021 were analyzed retrospectively. The patients met the diagnostic criteria of Sepsis-3 and were ≥ 18 years old. Peripheral venous blood samples were collected from all patients on the next morning after admission to SICU for routine blood test and peripheral blood lymphocyte subsets. According to the 28-day survival, the patients were divided into two groups, and the differences in immune indexes between the two groups were compared. Logistic regression analysis was used to analyze the risk factors of immune indexes that affect prognosis.
RESULTS: (1) A total of 279 patients with sepsis were enrolled in the experiment, of which 198 patients survived at 28 days (28-day survival rate 71.0%), and 81 patients died (28-day mortality 29.0%). There were no significant differences in age (years old: 57.81±1.71 vs. 54.99±1.05) and gender (male: 60.5% vs. 63.6%) between the death group and the survival group (both P > 0.05), and the baseline data was comparable.(2) Acute physiology and chronic health evalution II (APACHE II: 22.06±0.08 vs. 14.08±0.52, P < 0.001), neutrophil percentage [NEU%: (88.90±1.09)% vs. (84.12±0.77)%, P = 0.001], procalcitonin [PCT (μg/L): 11.97±2.73 vs. 5.76±1.08, P = 0.011], platelet distribution width (fL: 16.81±0.10 vs. 16.57±0.06, P = 0.029) were higher than those in the survival group, while lymphocyte percentage [LYM%: (6.98±0.78)% vs. (10.59±0.86)%, P = 0.012], lymphocyte count [LYM (×109/L): 0.70±0.06 vs. 0.98±0.49, P = 0.002], and platelet count [PLT (×109/L): 151.38±13.96 vs. 205.80±9.38, P = 0.002], and thrombocytocrit [(0.15±0.01)% vs. (0.19±0.07)%, P = 0.012] were lower than those in the survival group. (3) There was no statistically significant difference in the percentage of lymphocyte subsets between the death group and the survival group, but the absolute value of LYM (pieces/μL: 650.24±84.67 vs. 876.64±38.02, P = 0.005), CD3+ absolute value (pieces/μL: 445.30±57.33 vs. 606.84±29.25, P = 0.006), CD3+CD4+ absolute value (pieces/μL: 239.97±26.96 vs. 353.49±18.59, P = 0.001), CD19+ absolute value (pieces/μL: 111.10±18.66 vs. 150.30±10.15, P = 0.049) in the death group was lower than those in the survival group. Other lymphocyte subsets in the death group, such as CD3+CD8+ absolute value (pieces/μL: 172.40±24.34 vs. 211.22±11.95, P = 0.112), absolute value of natural killer cell [NK (pieces/μL): 101.26±18.15 vs. 114.72±7.64, P = 0.420], absolute value of natural killer T cell [NKT (pieces/μL): 33.22±5.13 vs. 39.43±2.85, P = 0.262], CD4-CD8- absolute value (pieces/μL: 41.07±11.07 vs. 48.84±3.31, P = 0.510), CD4+CD8+ absolute value (pieces/μL: 3.39±1.45 vs. 3.47±0.36, P = 0.943) were not significantly different from those in the survival group. (4)Logistic regression analysis showed that lymphocyte subsets were not selected as immune markers with statistical significance for the prognosis of sepsis.
CONCLUSIONS: The changes of immune indexes in sepsis patients are closely related to their prognosis. Early monitoring of the above indexes can accurately evaluate the condition and prognosis of sepsis patients.
参考来源
- Yang H, Li P, Cui Q, et al. [Analysis of lymphocyte subsets in patients with sepsis and its impact on prognosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37545446. doi:10.3760/cma.j.cn121430-20221230-01135
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。